NCT07265245

Brief Summary

The goal of this retrospective interventional study is to learn whether a new consultation approach called M2-PRIME can help improve blood sugar control in people with type 2 diabetes who use insulin and have high blood sugar levels (HbA1c more than 8.5%). The main questions are:

  1. 1.Does using M2-PRIME during consultations help lower HbA1c (3-month average blood sugar level)?
  2. 2.Does using M2-PRIME help lower fasting blood sugar (FBS, morning blood sugar)?
  3. 3.Build rapport and review the participant's health and lifestyle,
  4. 4.Give simple advice about food, activity, and insulin use,
  5. 5.Use the "Garbage and Lorry" analogy to explain how the body handles sugar, 4. Educate regarding insulin self-adjustment and monitoring

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
2 months until next milestone

Results Posted

Study results publicly available

January 23, 2026

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

November 22, 2025

Results QC Date

December 13, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

type 2 diabetesanalogiesM2-PRIMEConsultation module

Outcome Measures

Primary Outcomes (1)

  • HbA1c

    HbA1c (%) at 6 months

    6 months

Secondary Outcomes (1)

  • Fasting Blood Sugar

    6 months

Study Arms (1)

M2-PRIME applied

EXPERIMENTAL

M2-PRIME

Behavioral: M2-PRIME

Interventions

M2-PRIMEBEHAVIORAL

Participants received consultations delivered using the M2-PRIME framework, which applies analogy-based education (e.g., the "Garbage and Lorry" model) to improve understanding of diabetes and insulin use.

M2-PRIME applied

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Established T2DM patients, already on insulin therapy regardless of the type of insulin or regime or duration of treatment
  • HbA1c at referral more than 8.5%
  • Already seen by diabetic educator or dietician prior to referral

You may not qualify if:

  • Pregnant or found to be pregnant during follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik Kesihatan Senawang

Seremban, Negeri Sembilan, 70450, Malaysia

Location

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

Firstly, the study design lacks a control group. Secondly, the relatively high loss to follow-up (16.8%) raises the possibility of selection bias. Thirdly, the short 6-month follow-up period limits conclusions about the long-term sustainability of glycaemic control.

Results Point of Contact

Title
Dr. Hanif Omar
Organization
Ministry of Health Malaysia

Study Officials

  • MUHAMMAD HANIF B OMAR, MICGP

    Ministry of Health, Malaysia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 22, 2025

First Posted

December 4, 2025

Study Start

January 1, 2023

Primary Completion

July 1, 2023

Study Completion

January 1, 2025

Last Updated

January 23, 2026

Results First Posted

January 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The data and materials necessary to reproduce the findings that includes all of the individual participant data collected during the trial, after de-identification, Study Protocol, Statistical Analysis Plan, Clinical, Study Report, Analytic Code will be made available immediately following publication with no end date. Anyone can access the data, and the data can be used for any purpose. Data are available indefinitely at Open Science Framework https://osf.io/v26ku/overview

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
immediately
Access Criteria
Anyone can access the data, and the data can be used for any purpose
More information

Available IPD Datasets

IPD Approval letter (MREC APPROVAL LETTER)Access

Locations